Evidence map›Paper›PMID 38700592›Full record

ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2024

Artificial intelligence-based differential diagnosis of orbital MALT lymphoma and IgG4 related ophthalmic disease using hematoxylin-eosin images.

Mizuki Tagami, Mizuho Nishio, Atsuko Yoshikawa, Norihiko Misawa, Atsushi Sakai, Yusuke Haruna, Mami Tomita, Atsushi Azumi, Shigeru Honda

Abstract read
PubMed Publisher
In one paragraph

Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mizuki TagamiDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan. mizuki1979feb@yahoo.co.jp.ORCID http://orcid.org/0000-0002-8771-7252
Mizuho NishioCenter for Advanced Medical Engineering Research & Development, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
Atsuko YoshikawaOphthalmology Department and Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan.
Norihiko MisawaDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan.
Atsushi SakaiDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan.
Yusuke HarunaDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan.
Mami TomitaDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan.
Atsushi AzumiOphthalmology Department and Eye Center, Kobe Kaisei Hospital, Kobe, Hyogo, Japan.
Shigeru HondaDepartment of Ophthalmology and Visual Sciences,, Graduate School of Medicine, Osaka Metropolitan University, 1-5-7 Asahimachi, Abeno-Ku, Osaka-Shi, Osaka, 545-8586, Japan.

Funding

Charitable Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical's Founder 2022Japan Society for the Promotion of Science 22K07665Japan Society for the Promotion of Science KAKENHI 23K09013Osaka Community Foundation 2023
6 · The paper itself

Abstract

purposeTo investigate the possibility of distinguishing between IgG4-related ophthalmic disease (IgG4-ROD) and orbital MALT lymphoma using artificial intelligence (AI) and hematoxylin-eosin (HE) images.

methodsAfter identifying a total of 127 patients from whom we were able to procure tissue blocks with IgG4-ROD and orbital MALT lymphoma, we performed histological and molecular genetic analyses, such as gene rearrangement. Subsequently, pathological HE images were collected from these patients followed by the cutting out of 10 different image patches from the HE image of each patient. A total of 970 image patches from the 97 patients were used to construct nine different models of deep learning, and the 300 image patches from the remaining 30 patients were used to evaluate the diagnostic performance of the models. Area under the curve (AUC) and accuracy (ACC) were used for the performance evaluation of the deep learning models. In addition, four ophthalmologists performed the binary classification between IgG4-ROD and orbital MALT lymphoma.

resultsEVA, which is a vision-centric foundation model to explore the limits of visual representation, was the best deep learning model among the nine models. The results of EVA were ACC = 73.3% and AUC = 0.807. The ACC of the four ophthalmologists ranged from 40 to 60%.

conclusionsIt was possible to construct an AI software based on deep learning that was able to distinguish between IgG4-ROD and orbital MALT. This AI model may be useful as an initial screening tool to direct further ancillary investigations.

Indexed as

Artificial IntelligenceImmunoglobulin GLymphoma, B-Cell, Marginal ZoneOrbital NeoplasmsAdultAgedDeep LearningDiagnosis, DifferentialFemaleHematoxylinHumansImmunoglobulin G4-Related DiseaseMaleMiddle AgedRetrospective StudiesROC CurveHematoxylinImmunoglobulin GArtificial intelligence (AI)Deep learningHematoxylin–eosin (HE)IgG4-related ophthalmic disease (IgG4-ROD)Orbital MALT lymphoma

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.